Holzer Holzer & Fistel, LLC Announces Investigation Into The Proposed Buyout Of Somanetics By Covidien Plc

Holzer Holzer & Fistel, LLC is investigating whether the directors of Somanetics Corporation (“Somanetics” or the “Company”) (NASDAQ: SMTS) complied with their fiduciary duties in approving the proposed buyout of the Company by Covidien plc (NYSE: COV). According to the terms of the agreement, Somanetics shareholders would receive $25.00 per share if the deal is approved. The investigation seeks to determine if the consideration to be paid to Somanetics shareholders is fair and adequate.

Current holders of Somanetics common stock with questions concerning their legal rights are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel, Jr., Esq. or Marshall P. Dees, Esq. via email at [e-mail] or [e-mail], or via toll-free telephone at [phone].

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

>To order reprints of this article, click here: Reprints